Charlton Ralph William III bought SPRB
March 14, 2024 · Form 4 insider transaction
Charlton Ralph William III bought 106,400 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
106,400
Price
$0.00
Total value
N/A
InsiderCharlton Ralph William III
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 14, 2024
Filing dateMarch 18, 2024
Shares owned after106,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of SPRB common stock.; Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective.